Jeremy Marsden

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami et al. · The Lancet · 2008 · 642 citations

Medicine, Oncology, Pharmacotherapy +14

Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

Alexander M.M. Eggermont, Stefan Suciu, Alessandro Testori et al. · Journal of Clinical Oncology · 2012 · 282 citations · Full text

Medicine, Oncology, Immunotherapy +16

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group

Andrew Bottomley, Corneel Coens, Stefan Suciu et al. · Journal of Clinical Oncology · 2009 · 116 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial

Alexander M.M. Eggermont, Stefan Suciu, Piotr Rutkowski et al. · Journal of Clinical Oncology · 2013 · 106 citations · Full text

Medicine, Immunology, Oncology +17

Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid function

Jeremy Marsden, Thomas R. Trinick, M F Laker et al. · Clinica Chimica Acta · 1984 · 42 citations

Life Sciences, Endocrinology, Pharmacology +14